No Result

View All Result

No products in the cart.

Home The 2MM Team

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

byKathleen Lau

December 25, 2020

in The 2MM Team

Reading Time: 1 min read

Check out the original article from the Lancet Haematology here.

RELATED REPORTS

Structured exercise intervention improves survival in colon cancer patients

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

AAV gene therapy shows durable benefit in hemophilia B

COVID-19 susceptibility may be increased in patients with hematological malignancies compared to solid organ tumours

RelatedReports

Development of a risk index for colorectal cancer screening

Gastroenterology

Structured exercise intervention improves survival in colon cancer patients

July 9, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

July 8, 2025

Primary thromboembolism prophylaxis may be effective in advanced cancer

Hematology

AAV gene therapy shows durable benefit in hemophilia B

July 7, 2025

Lessons from real-world implementation of lung cancer screening

Oncology

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

July 7, 2025

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Regular screening of asymptomatic SARS-CoV-2 carriers may limit COVID-19 transmission

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result